FRACTYL HEALTH, INC. (GUTS)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Revenue | - | - | 14 | |
| Cost of goods sold | - | - | 7 | |
| Gross profit | - | - | 7 | |
| Selling, general and administrative | 4,928 | 5,324 | 4,797 | |
| Research and development | 21,151 | 19,435 | 19,004 | |
| Total operating expenses | 26,079 | 24,759 | 23,801 | |
| Loss from operations | -26,079 | -24,759 | -23,794 | |
| Other expense, net | -15 | -21 | -9 | |
| Interest income, net | 226 | 503 | 947 | |
| Change in fair value of warrant liabilities | 348 | -825 | -2,293 | |
| Change in fair value of notes payable | 1,673 | 283 | 2,610 | |
| Total other income (expense), net | -1,810 | 1,024 | 621 | |
| Net loss and comprehensive loss | -27,889 | -23,735 | -23,173 | |
| Net loss attributable to common stockholders | -27,889 | -23,735 | -23,173 | |
| Earnings per share, basic, total | -0.57 | -0.49 | -0.48 | |
| Earnings per share, diluted, total | -0.57 | -0.49 | -0.48 | |
| Weighted average number of shares outstanding, basic, total | 49,042,926 | 48,865,468 | 47,973,951 | |
| Weighted average number of shares outstanding, diluted, total | 49,042,926 | 48,865,468 | 47,973,951 | |